News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Trading in Novo Nordisk A/S (NVO) Shares by Board Members, Executives and Associated Persons on 8 August 2013


8/9/2013 8:38:44 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BAGSVAERD, DENMARK--(Marketwired - August 09, 2013) - In accordance with Section 28a of the Danish Securities Trading Act, the company's board members and executives have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons as reported by those persons to Novo Nordisk.

Company Announcement No 55 2013: http://hugin.info/2013/R/1722251/573731.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1722251]


Further information:
Media:
Anne Margrethe Hauge
Tel: +45 4442 3450
Email Contact

Ken Inchausti (US)
Tel: +1 609 514 8316
Email Contact

Investors:
Kasper Roseeuw Poulsen
Tel: +45 4442 4303
Email Contact

Frank Daniel Mersebach
Tel: +45 4442 0604
Email Contact

Lars Borup Jacobsen
Tel: +45 3075 3479
Email Contact

Jannick Lindegaard (US)
Tel: +1 609 786 4575
Email Contact

Daniel Bohsen
+45 3079 6376
Email Contact



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES